Keywords: schering-plough, net, income, up, second-quarter, rose, 634million
Schering-Plough net income up 16%
Article | 26 July 2000
Schering-Plough's second-quarter 2000 net income rose 16% to $634million, or $0.43 per share, as sales climbed 8% to $2.64 billion. Worldwide pharmaceutical sales rose 8% to $2.24 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
